Exact Sciences | EXAS


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Agilent 117.73 -2.69 -2.23% -7.71%
Accelerate Diagnostics 0.68 -0.06 -8.50% 10.97%
Becton, Dickinson and Co. 238.39 -2.73 -1.13% -6.81%
Bio-Rad Laboratories 379.76 0.76 0.20% -29.39%
Bruker 70.29 -1.31 -1.83% 12.50%
Charles River Laboratories 196.05 1.93 0.99% -16.25%
Danaher 227.13 -5.03 -2.17% -13.91%
Exact Sciences 81.14 -0.87 -1.06% 62.90%
Hologic 78.66 -0.37 -0.47% 4.50%
Illumina 194.51 -1.38 -0.70% -18.78%
Mesa Laboratories 132.86 -7.84 -5.57% -36.51%
Mettler Toledo International 1,314.72 -33.47 -2.48% 2.22%
Myriad Genetics 22.26 -0.03 -0.13% 15.70%
NanoString Technologies 6.08 0.30 5.19% -61.13%
OraSure Technologies 4.91 0.03 0.61% 18.31%
PerkinElmer 116.22 -0.45 -0.39% -22.35%
Quidel 86.49 0.95 1.11% -8.99%
Repligen 173.34 2.32 1.36% 5.39%
STAAR Surgical 58.00 -1.79 -2.99% -12.04%
Bio Techne 83.18 -0.32 -0.38% -10.01%
Thermo Fisher Scientific 514.41 -7.80 -1.49% -9.37%
Veracyte 25.68 0.10 0.39% 46.08%
Waters 255.57 -5.04 -1.93% -22.07%

Indexes Price Day Year
USND 13017 41.74 0.32% 7.75%
US2000 1767 -5.73 -0.32% -5.19%

Exact Sciences

Exact Sciences traded at $81.14 this Tuesday May 30th, decreasing $0.87 or 1.06 percent since the previous trading session. Looking back, over the last four weeks, Exact Sciences lost 27.96 percent. Over the last 12 months, its price rose by 62.90 percent. Looking ahead, we forecast Exact Sciences to be priced at 79.65 by the end of this quarter and at 72.96 in one year, according to Trading Economics global macro models projections and analysts expectations.

Exact Sciences Corporation is a cancer screening and diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect deoxyribonucleic acid (DNA) and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Cologuard test is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. It focuses on the development of additional tests for other types of cancer. It is developing a blood-based biomarker test to aid in the early detection of lung cancer in individuals with lung nodules discovered through a computerized tomography (CT) scan.